🎙️ EP 177: Meta’s Manus Move Sparks China Clash + PANDA AI Catches Cancer Doctors Missed

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

Two billion dollars. One AI startup. And now China’s watching.

Today’s episode dives into Meta’s Manus acquisition and the regulatory heat from Beijing that could shake up how Chinese AI startups exit. We’ll also cover Alibaba’s PANDA AI, which just flagged pancreatic cancer cases, even ones human doctors missed.

You’ll hear about:

• Why China’s regulators might block Meta’s Manus deal (and what "Singapore-washing" means)
• PANDA AI’s breakthrough in early cancer detection from low-contrast CT scans
• Claude Code compressing 1 year of engineering into 1 hour
• ChatGPT’s 2026 roadmap to become your "super assistant"
• xAI’s $20B raise and aggressive hiring spree
• Amazon’s Alexa+ goes web-based to take on ChatGPT and Gemini

Keywords: Meta Manus, pancreatic cancer, Alibaba DAMO, xAI, Claude Code, ChatGPT assistant, AI fundraising

Links:

1. Newsletter: Sign up for our FREE daily newsletter.
2. Our Community: Get 3-level AI tutorials across industries.
3. Join AI Fire Academy: 500+ advanced AI workflows ($14,500+ Value)

Our Socials:

1. Facebook Group: Join 275K+ AI builders
2. X (Twitter): Follow us for daily AI drops
3. YouTube: Watch AI walkthroughs & tutorials